• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $LMRI

    Lumexa Imaging Holdings Inc.

    Subscribe to $LMRI
    $LMRI
    Medical Specialities
    Health Care

    IPO Year: 2025

    Exchange: NASDAQ

    Recent Analyst Ratings for Lumexa Imaging Holdings Inc.

    DatePrice TargetRatingAnalyst
    2/9/2026$23.00Outperform → Strong Buy
    Raymond James
    1/5/2026$23.00Overweight
    Analyst
    1/5/2026$23.00Buy
    Jefferies
    1/5/2026$22.00Overweight
    Wells Fargo
    1/5/2026Outperform
    William Blair
    1/5/2026$23.00Outperform
    Raymond James
    1/5/2026$23.00Outperform
    Leerink Partners
    1/5/2026$22.00Buy
    Deutsche Bank
    1/5/2026$23.00Overweight
    Barclays
    See more ratings

    Lumexa Imaging Holdings Inc. SEC Filings

    View All

    SEC Form 10-Q filed by Lumexa Imaging Holdings Inc.

    10-Q - Lumexa Imaging Holdings, Inc. (0002071288) (Filer)

    5/12/26 4:15:47 PM ET
    $LMRI
    Medical Specialities
    Health Care

    Lumexa Imaging Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure

    8-K - Lumexa Imaging Holdings, Inc. (0002071288) (Filer)

    5/12/26 4:08:46 PM ET
    $LMRI
    Medical Specialities
    Health Care

    SEC Form DEFA14A filed by Lumexa Imaging Holdings Inc.

    DEFA14A - Lumexa Imaging Holdings, Inc. (0002071288) (Filer)

    4/28/26 4:37:06 PM ET
    $LMRI
    Medical Specialities
    Health Care

    SEC Form DEF 14A filed by Lumexa Imaging Holdings Inc.

    DEF 14A - Lumexa Imaging Holdings, Inc. (0002071288) (Filer)

    4/28/26 4:36:16 PM ET
    $LMRI
    Medical Specialities
    Health Care

    Lumexa Imaging Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure

    8-K - Lumexa Imaging Holdings, Inc. (0002071288) (Filer)

    4/9/26 5:11:27 PM ET
    $LMRI
    Medical Specialities
    Health Care

    SEC Form 10-K filed by Lumexa Imaging Holdings Inc.

    10-K - Lumexa Imaging Holdings, Inc. (0002071288) (Filer)

    3/30/26 5:32:34 PM ET
    $LMRI
    Medical Specialities
    Health Care

    Lumexa Imaging Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure

    8-K - Lumexa Imaging Holdings, Inc. (0002071288) (Filer)

    3/26/26 6:09:21 AM ET
    $LMRI
    Medical Specialities
    Health Care

    Lumexa Imaging Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure

    8-K - Lumexa Imaging Holdings, Inc. (0002071288) (Filer)

    3/2/26 6:14:27 AM ET
    $LMRI
    Medical Specialities
    Health Care

    SEC Form SCHEDULE 13G filed by Lumexa Imaging Holdings Inc.

    SCHEDULE 13G - Lumexa Imaging Holdings, Inc. (0002071288) (Subject)

    2/13/26 2:36:25 PM ET
    $LMRI
    Medical Specialities
    Health Care

    SEC Form 8-K filed by Lumexa Imaging Holdings Inc.

    8-K - Lumexa Imaging Holdings, Inc. (0002071288) (Filer)

    1/15/26 6:48:58 AM ET
    $LMRI
    Medical Specialities
    Health Care

    Lumexa Imaging Holdings Inc. Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Brodnax Brett bought $253,750 worth of shares (35,000 units at $7.25), increasing direct ownership by 130% to 62,027 units (SEC Form 4)

    4 - Lumexa Imaging Holdings, Inc. (0002071288) (Issuer)

    5/21/26 4:20:16 PM ET
    $LMRI
    Medical Specialities
    Health Care

    Director Cooper Henry Lee bought $223,113 worth of shares (30,000 units at $7.44) (SEC Form 4)

    4 - Lumexa Imaging Holdings, Inc. (0002071288) (Issuer)

    5/18/26 4:12:52 PM ET
    $LMRI
    Medical Specialities
    Health Care

    Principal Accounting Officer Walker James Edward Jr. was granted 12,414 shares, increasing direct ownership by 252% to 17,346 units (SEC Form 4)

    4 - Lumexa Imaging Holdings, Inc. (0002071288) (Issuer)

    2/27/26 5:40:01 PM ET
    $LMRI
    Medical Specialities
    Health Care

    Chief Financial Officer Martin James Anthony was granted 54,054 shares (SEC Form 4)

    4 - Lumexa Imaging Holdings, Inc. (0002071288) (Issuer)

    1/15/26 12:51:17 PM ET
    $LMRI
    Medical Specialities
    Health Care

    SEC Form 3 filed by new insider Martin James Anthony

    3 - Lumexa Imaging Holdings, Inc. (0002071288) (Issuer)

    1/15/26 12:49:28 PM ET
    $LMRI
    Medical Specialities
    Health Care

    Principal Accounting Officer Walker James Edward Jr. was granted 4,932 shares (SEC Form 4)

    4 - Lumexa Imaging Holdings, Inc. (0002071288) (Issuer)

    12/30/25 2:01:12 PM ET
    $LMRI
    Medical Specialities
    Health Care

    SEC Form 3 filed by new insider Walker James Edward Jr.

    3 - Lumexa Imaging Holdings, Inc. (0002071288) (Issuer)

    12/30/25 1:58:28 PM ET
    $LMRI
    Medical Specialities
    Health Care

    SEC Form 3 filed by new insider Mittl Robert Louis Jr.

    3 - Lumexa Imaging Holdings, Inc. (0002071288) (Issuer)

    12/18/25 10:13:26 AM ET
    $LMRI
    Medical Specialities
    Health Care

    Chief Executive Officer Zulla Caitlin was granted 129,728 shares (SEC Form 4)

    4 - Lumexa Imaging Holdings, Inc. (0002071288) (Issuer)

    12/16/25 5:50:06 PM ET
    $LMRI
    Medical Specialities
    Health Care

    Director Brodnax Brett was granted 27,027 shares (SEC Form 4)

    4 - Lumexa Imaging Holdings, Inc. (0002071288) (Issuer)

    12/16/25 5:49:53 PM ET
    $LMRI
    Medical Specialities
    Health Care

    Lumexa Imaging Holdings Inc. Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Brodnax Brett bought $253,750 worth of shares (35,000 units at $7.25), increasing direct ownership by 130% to 62,027 units (SEC Form 4)

    4 - Lumexa Imaging Holdings, Inc. (0002071288) (Issuer)

    5/21/26 4:20:16 PM ET
    $LMRI
    Medical Specialities
    Health Care

    Director Cooper Henry Lee bought $223,113 worth of shares (30,000 units at $7.44) (SEC Form 4)

    4 - Lumexa Imaging Holdings, Inc. (0002071288) (Issuer)

    5/18/26 4:12:52 PM ET
    $LMRI
    Medical Specialities
    Health Care

    Lumexa Imaging Holdings Inc. Press Releases

    Fastest customizable press release news feed in the world

    View All

    Lumexa Imaging Announces Joint Venture with Hospital for Special Surgery (HSS) to Expand Advanced Outpatient Imaging in New York

    RALEIGH, N.C., June 02, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (NASDAQ:LMRI), one of the nation's largest providers of outpatient imaging services, today announced the formation of a strategic joint venture with Hospital for Special Surgery (HSS), world leader in musculoskeletal health. The collaboration represents Lumexa Imaging's ninth joint venture and further strengthens the company's presence in New York—one of the nation's largest healthcare markets. Lumexa Imaging and HSS plan to expand access to advanced outpatient imaging services across the New York City metro area, bringing high-quality, convenient care closer to patients and referring providers. This announcement reflects co

    6/2/26 7:00:00 AM ET
    $LMRI
    Medical Specialities
    Health Care

    Lumexa Imaging Announces First Quarter 2026 Results

    RALEIGH, N.C., May 12, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (NASDAQ:LMRI), one of the nation's largest providers of outpatient imaging services, today announced results for the first quarter ended March 31, 2026, and reiterated full year 2026 guidance.  "In Q1, we delivered several meaningful achievements to kick off a year of executing on our strategic priorities," said Caitlin Zulla, Chief Executive Officer of Lumexa Imaging. "We continued to drive strong growth in same-center advanced imaging volumes and our de novo centers are ramping according to our plans." "We are also announcing tonight four additional Lumexa Imaging centers including two strategic tuck-in acquisitions plus tw

    5/12/26 4:07:00 PM ET
    $LMRI
    Medical Specialities
    Health Care

    Lumexa Imaging Advances Growth Strategy by Adding Four New Imaging Centers

    RALEIGH, N.C., May 12, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (NASDAQ:LMRI), one of the nation's largest providers of outpatient imaging services, today announced the addition of four new locations in 2026 as part of its continued execution against a disciplined, multi-channel growth strategy. The new centers are located in Spartanburg, South Carolina; Concord, North Carolina; Wexford, Pennsylvania; and Niceville, Florida. Two of the new locations were added through acquisitions with Lumexa Imaging's joint venture partners, Advocate Health and UPMC, further advancing Lumexa Imaging's strategy to expand in high-growth markets through partnerships with leading health systems. With these tw

    5/12/26 4:05:00 PM ET
    $LMRI
    Medical Specialities
    Health Care

    Lumexa Imaging Announces First Quarter 2026 Earnings Conference Call Date

    RALEIGH, N.C., April 28, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (NASDAQ:LMRI), one of the nation's largest providers of outpatient imaging services, today announced it will release its first quarter 2026 financial and operational results after market close on Tuesday, May 12, 2026. The Company will host a conference call and live webcast to discuss the results at 5:00 p.m. ET. The live audio webcast will be available in the Investor Relations section of the Company's website at ir.lumexaimaging.com. A replay of the webcast will be available for approximately one year. About Lumexa Imaging Lumexa Imaging is a nationwide provider of outpatient medical imaging. With over 5,000 team member

    4/28/26 4:15:00 PM ET
    $LMRI
    Medical Specialities
    Health Care

    Lumexa Imaging Appoints Kyle Lynch as Chief Growth Officer

    RALEIGH, N.C., April 20, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (NASDAQ:LMRI), one of the nation's largest providers of outpatient imaging services, today announced the appointment of Kyle Lynch as its new Chief Growth Officer (CGO). Lynch joins the executive leadership team to lead the company's enterprise growth strategy, with responsibility for expanding Lumexa Imaging's platform through joint ventures, acquisitions, and de novo development. In this role, Lynch will oversee the full growth lifecycle, including opportunity origination, transaction execution, and post-close value realization, with a focus on driving sustainable, profitable growth and maximizing return on invested capita

    4/20/26 7:00:00 AM ET
    $LMRI
    Medical Specialities
    Health Care

    Lumexa Imaging Announces Fourth Quarter and Full Year 2025 Results, Reiterates Full Year 2026 Guidance

    RALEIGH, N.C., March 26, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (NASDAQ:LMRI), one of the nation's largest providers of outpatient imaging services, today announced certain financial results for the fourth quarter ended December 31, 2025, and reiterated full year 2026 guidance. The financial results included in this release pertaining to the fourth quarter and full year 2025 are preliminary, unaudited, and subject to final review and adjustment. "The fourth quarter of 2025 marked a strong close to an important year for Lumexa Imaging, with continued momentum across the business," said Caitlin Zulla, Chief Executive Officer of Lumexa Imaging. "Strong Adjusted EBITDA growth was driven by a

    3/26/26 6:00:00 AM ET
    $LMRI
    Medical Specialities
    Health Care

    Middleby Appoints Glenn Eisenberg To Board of Directors

    The Middleby Corporation (NASDAQ:MIDD), a global leader in the foodservice industry, today announced the appointment of Glenn Eisenberg to its Board of Directors, effective March 1. With the addition of Mr. Eisenberg, the Middleby Board expands to twelve members. "We are pleased to welcome Glenn Eisenberg to the Middleby Board. His deep experience will be an immediate asset as we execute our strategic transformation," said Tim FitzGerald, Middleby CEO. "Glenn has a proven 20-year track record of success as a public company CFO and senior operating executive across complex global manufacturing businesses. His expertise in financial discipline, industrial manufacturing, capital allocation,

    3/6/26 7:00:00 AM ET
    $LH
    $LMRI
    $MIDD
    Medical Specialities
    Health Care
    Industrial Machinery/Components
    Industrials

    Lumexa Imaging Announces Participation in Upcoming Investor Conferences

    RALEIGH, N.C., Feb. 17, 2026 /PRNewswire/ -- Lumexa Imaging Holdings, Inc. ("Lumexa Imaging") (NASDAQ:LMRI), one of the nation's largest providers of outpatient imaging services, announced today that Caitlin Zulla, CEO, and Tony Martin, CFO, will participate in the following upcoming investor conferences: Raymond James Institutional Investors Conference, being held in Orlando, Florida, including a presentation at 3:25pm EST on Monday, March 2, 2026.Leerink Partners Global Healthcare Conference, being held in Miami, Florida, including a fireside chat at 8:40am EST on Monday, Marc

    2/17/26 7:30:00 AM ET
    $LMRI
    Medical Specialities
    Health Care

    Lumexa Imaging's Dr. Jennifer L. Kemp Elected to RSNA Board, Advancing National Leadership in Quality and Patient-Centered Care

    Chair of Lumexa Imaging's Center for Quality will serve as the Radiological Society of North America's board liaison for government relations RALEIGH, N.C., Jan. 28, 2026 /PRNewswire/ -- Lumexa Imaging (NASDAQ:LMRI), one of the nation's largest providers of outpatient imaging services, is proud to recognize Jennifer L. Kemp, MD, Chair of Lumexa Imaging's Center for Quality, has been elected to the Board of Directors of the Radiological Society of North America (RSNA). "Dr. Kemp's election to the RSNA Board reflects the depth of clinical leadership within our organization and t

    1/28/26 7:00:00 AM ET
    $LMRI
    Medical Specialities
    Health Care

    Lumexa Imaging Achieves Record De Novo Expansion in 2025

    Company opens nine new outpatient imaging centers, expanding access to high-quality, cost-effective care RALEIGH, N.C., Jan. 8, 2026 /PRNewswire/ -- Lumexa Imaging (NASDAQ:LMRI), one of the nation's largest providers of outpatient imaging services, set a company record by opening nine de novo centers in 2025. The two newest centers, located in Anderson, South Carolina and Cotswold, North Carolina, opened in December. With these new locations Lumexa Imaging now operates more than 185 centers across 13 states. The prior 2025 openings took place across New York, South Carolina and Texas.

    1/8/26 7:00:00 AM ET
    $LMRI
    Medical Specialities
    Health Care

    Lumexa Imaging Holdings Inc. Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Lumexa Imaging Holdings upgraded by Raymond James with a new price target

    Raymond James upgraded Lumexa Imaging Holdings from Outperform to Strong Buy and set a new price target of $23.00

    2/9/26 8:16:45 AM ET
    $LMRI
    Medical Specialities
    Health Care

    Analyst initiated coverage on Lumexa Imaging Holdings with a new price target

    Analyst initiated coverage of Lumexa Imaging Holdings with a rating of Overweight and set a new price target of $23.00

    1/5/26 9:16:52 AM ET
    $LMRI
    Medical Specialities
    Health Care

    Jefferies initiated coverage on Lumexa Imaging Holdings with a new price target

    Jefferies initiated coverage of Lumexa Imaging Holdings with a rating of Buy and set a new price target of $23.00

    1/5/26 8:58:21 AM ET
    $LMRI
    Medical Specialities
    Health Care

    Wells Fargo initiated coverage on Lumexa Imaging Holdings with a new price target

    Wells Fargo initiated coverage of Lumexa Imaging Holdings with a rating of Overweight and set a new price target of $22.00

    1/5/26 8:58:11 AM ET
    $LMRI
    Medical Specialities
    Health Care

    William Blair initiated coverage on Lumexa Imaging Holdings

    William Blair initiated coverage of Lumexa Imaging Holdings with a rating of Outperform

    1/5/26 8:58:11 AM ET
    $LMRI
    Medical Specialities
    Health Care

    Raymond James initiated coverage on Lumexa Imaging Holdings with a new price target

    Raymond James initiated coverage of Lumexa Imaging Holdings with a rating of Outperform and set a new price target of $23.00

    1/5/26 8:58:11 AM ET
    $LMRI
    Medical Specialities
    Health Care

    Leerink Partners initiated coverage on Lumexa Imaging Holdings with a new price target

    Leerink Partners initiated coverage of Lumexa Imaging Holdings with a rating of Outperform and set a new price target of $23.00

    1/5/26 8:57:50 AM ET
    $LMRI
    Medical Specialities
    Health Care

    Deutsche Bank initiated coverage on Lumexa Imaging Holdings with a new price target

    Deutsche Bank initiated coverage of Lumexa Imaging Holdings with a rating of Buy and set a new price target of $22.00

    1/5/26 8:57:39 AM ET
    $LMRI
    Medical Specialities
    Health Care

    Barclays initiated coverage on Lumexa Imaging Holdings with a new price target

    Barclays initiated coverage of Lumexa Imaging Holdings with a rating of Overweight and set a new price target of $23.00

    1/5/26 8:21:55 AM ET
    $LMRI
    Medical Specialities
    Health Care

    Lumexa Imaging Holdings Inc. Leadership Updates

    Live Leadership Updates

    View All

    Lumexa Imaging Appoints Kyle Lynch as Chief Growth Officer

    RALEIGH, N.C., April 20, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (NASDAQ:LMRI), one of the nation's largest providers of outpatient imaging services, today announced the appointment of Kyle Lynch as its new Chief Growth Officer (CGO). Lynch joins the executive leadership team to lead the company's enterprise growth strategy, with responsibility for expanding Lumexa Imaging's platform through joint ventures, acquisitions, and de novo development. In this role, Lynch will oversee the full growth lifecycle, including opportunity origination, transaction execution, and post-close value realization, with a focus on driving sustainable, profitable growth and maximizing return on invested capita

    4/20/26 7:00:00 AM ET
    $LMRI
    Medical Specialities
    Health Care

    Middleby Appoints Glenn Eisenberg To Board of Directors

    The Middleby Corporation (NASDAQ:MIDD), a global leader in the foodservice industry, today announced the appointment of Glenn Eisenberg to its Board of Directors, effective March 1. With the addition of Mr. Eisenberg, the Middleby Board expands to twelve members. "We are pleased to welcome Glenn Eisenberg to the Middleby Board. His deep experience will be an immediate asset as we execute our strategic transformation," said Tim FitzGerald, Middleby CEO. "Glenn has a proven 20-year track record of success as a public company CFO and senior operating executive across complex global manufacturing businesses. His expertise in financial discipline, industrial manufacturing, capital allocation,

    3/6/26 7:00:00 AM ET
    $LH
    $LMRI
    $MIDD
    Medical Specialities
    Health Care
    Industrial Machinery/Components
    Industrials

    Lumexa Imaging Holdings Inc. Financials

    Live finance-specific insights

    View All

    Lumexa Imaging Announces First Quarter 2026 Results

    RALEIGH, N.C., May 12, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (NASDAQ:LMRI), one of the nation's largest providers of outpatient imaging services, today announced results for the first quarter ended March 31, 2026, and reiterated full year 2026 guidance.  "In Q1, we delivered several meaningful achievements to kick off a year of executing on our strategic priorities," said Caitlin Zulla, Chief Executive Officer of Lumexa Imaging. "We continued to drive strong growth in same-center advanced imaging volumes and our de novo centers are ramping according to our plans." "We are also announcing tonight four additional Lumexa Imaging centers including two strategic tuck-in acquisitions plus tw

    5/12/26 4:07:00 PM ET
    $LMRI
    Medical Specialities
    Health Care

    Lumexa Imaging Announces First Quarter 2026 Earnings Conference Call Date

    RALEIGH, N.C., April 28, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (NASDAQ:LMRI), one of the nation's largest providers of outpatient imaging services, today announced it will release its first quarter 2026 financial and operational results after market close on Tuesday, May 12, 2026. The Company will host a conference call and live webcast to discuss the results at 5:00 p.m. ET. The live audio webcast will be available in the Investor Relations section of the Company's website at ir.lumexaimaging.com. A replay of the webcast will be available for approximately one year. About Lumexa Imaging Lumexa Imaging is a nationwide provider of outpatient medical imaging. With over 5,000 team member

    4/28/26 4:15:00 PM ET
    $LMRI
    Medical Specialities
    Health Care